Diana Domanska

Has grant

Senior researcher

Oslo University Hospital
Country flagNorway

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Uncovering the pathology of acute GVHD in allogeneic stem cell transplantation for therapeutic targeting

Open Date: 2025-01-01

Close Date:

Grant: Close

Dissecting the tumor microenvironment in colorectal liver metastases to identify new targets for cancer treatment

Open Date: 2024-01-01

Close Date:

Grant: Close

Ulcerative colitis: Identifying biomarkers to determine which patients that can discontinue anti-TNF treatment

Open Date: 2023-01-01

Close Date:

Grant: Close

Spatial transcriptomics to predict treatment response in Crohn’s disease

Open Date: 2022-01-01

Close Date:

Grant: Close

Immunotherapy targeting tumour-associated macrophages in colorectal cancer

Open Date: 2022-01-01

Close Date:

Articles (5)

Year:

2025

Year:

2025

It has been reported that microsatellite instable (MSI) tumors in colorectal cancer (CRC) exhibit stronger anti-tumor responses than microsatellite stable (MSS) tumors. Analyzing scRNA-seq data from 185 CRC patients we found that immune, structural, and cancer cells in MSS tumors with high numbers of tumor-infiltrating CD8 T cells and macrophages (TAMs; CD8 hi TAM hi ) and CD8 low TAM hi tumors were enriched for pathways associated with anti- and pro-tumor responses, respectively. In CD8 hi TAM hi tumors, TAMs expressed an IFN-induced phenotype (e.g. GBP1, CXCL9, IFITM3 ) and high infiltration of GBP1 + TAMs was associated with better overall survival (n=941). High-resolution spatial transcriptomics (Visium HD) revealed that GBP1 + TAMs clustered with CXCL13 + IFNG+PDCD1+ CD8 T cells in tumoral niches, suggesting that GBP1 + TAMs were involved in recruitment and activation of tumor-reactive CD8 T cells. Together, we uncovered coordinated cellular programs across cell types in the microenvironment of MSS tumors, based on simple classification variables, that were strongly associated with prognosis.

Year:

2025

Year:

2023

Year:

2023

Collaborators (5)

Sheraz Yaqub

Full Professor of Surgery

University of Oslo

NORWAY
View details

Torbjørn Rognes

Professor

University of Oslo

NORWAY
View details

Frode Jahnsen

Professor at University of Oslo

University of Oslo

NORWAY
View details

Fred Haugen

Research group leader/ Research Professor

National Institute of Occupational Health

NORWAY
View details

Eivind Hovig

Professor/ Head, Center of Bioinformatics

University of Oslo

NORWAY
View details